Kidney Cancer Features

Physician Polls Are you surprised that targeted therapeutics for metastatic renal cell carcinoma (RCC) have not improved survival?

Are you surprised that targeted therapeutics for metastatic renal cell carcinoma (RCC) have not improved survival?

A study found that targeted therapeutic agents for treating metastatic RCC has not led to an improvement in survival rates.

Commentary Personalized Medicine in 2014

Personalized Medicine in 2014

The term "personalized medicine" remains an overused promise to apply specific treatment plans.

Kidney Cancer Videos

Latest Kidney Cancer News

Post-Transplant Urologic Cancers More Likely in Women

Post-Transplant Urologic Cancers More Likely in Women

In adjusted analyses, female transplant recipients had a significantly increased risk of urologic cancer and men did not.

Kidney, Thyroid Cancers on the Rise in Children

Kidney, Thyroid Cancers on the Rise in Children

Study also finds increase in overall cancer rate among African-American children and adolescents.

Chronic Kidney Disease (CKD) Predicts Acute Kidney Injury (AKI) After Renal Cell Carcinoma Surgery

Chronic Kidney Disease (CKD) Predicts Acute Kidney Injury (AKI) After Renal Cell Carcinoma Surgery

Other predictors include neurovascular disease, obesity, and surgical approach.

Advanced Kidney Cancer Survival Rates Not Improved

Advanced Kidney Cancer Survival Rates Not Improved

The 3-year survival rates for patients diagnosed during 2006-2007 were similar to those diagnosed during 2001-2005.

Depression in Cancer Patients Often Untreated

Depression in Cancer Patients Often Untreated

Studies show integrated program effective for depression in patients with cancer.

High CRP Predicts Poor RCC-Specific Survival in Hemodialysis Patients

High CRP Predicts Poor RCC-Specific Survival in Hemodialysis Patients

Study shows a 3.5 times increased risk of death from renal cancer in hemodialysis patients undergoing nephrectomy.

End-Stage Renal Disease (ESRD) Risk Lower with Partial Nephrectomy

End-Stage Renal Disease (ESRD) Risk Lower with Partial Nephrectomy

Researchers find a greater than 50% reduction in end-stage renal disease risk compared with radical nephrectomy.

Obesity Ups Bladder, Kidney Cancer Risk in Men

Obesity Ups Bladder, Kidney Cancer Risk in Men

As body mass index increases, so does the risk of kidney and bladder cancers in men and stomach, ovarian, and colon cancers in women.

Prostate Cancer Patients Face Higher Risk of Second Malignancies

Prostate Cancer Patients Face Higher Risk of Second Malignancies

Study reveals a 2-fold greater likelihood of primary kidney and bladder cancer compared with men in the general population.

Visceral Fat Area Predicts Kidney Cancer Subtype

Visceral Fat Area Predicts Kidney Cancer Subtype

Increased abdominal adiposity is associated with a greater likelihood of clear-cell renal cell carcinoma.

Partial Nephrectomy Superior Despite Kidney Tumor Size

Partial Nephrectomy Superior Despite Kidney Tumor Size

Renal function is preserved better compared with radical nephrectomy even when tumors are larger than the traditional 4 cm cutoff.

Renal Tumor Risk Higher in Lithium-Treated Patients

Renal Tumor Risk Higher in Lithium-Treated Patients

Renal tumors occur at a frequency 7.5 times greater in lithium-treated patients than in the general population, French study shows.

Nephron Sparing Surgery Okay for Tumors in Transplanted Kidneys

Nephron Sparing Surgery Okay for Tumors in Transplanted Kidneys

At last follow-up, 41 of 43 patients who underwent partial nephrectomy did not require dialysis.

High Cholesterol Predicts Better RCC Outcomes

High Cholesterol Predicts Better RCC Outcomes

Patients with levels of 161.5 mg/dL or greater had a 43% decreased risk of death from renal cell carcinoma than those with lower levels.

Pre-Existing HTN Predicts Better Survival in Sunitinib Recipients

Pre-Existing HTN Predicts Better Survival in Sunitinib Recipients

The finding emerged from a French study of 213 patients with metastatic renal cell carcinoma.